Sigvotatug vedotin

(Synonyms: SGN-B6A; PF-08046047)
고객리뷰

Based on 1 Customer Validation

Sigvotatug vedotin (SGN-B6A; PF-08046047) is an ADC that targets integrin β-6 (ITGB6) via the human IgG1 monoclonal antibody Sigvotatug (HY-P990764) (EC50 = 0.9 nM) and exhibits cytotoxicity against a variety of integrin β-6-positive cancer cells through the tubulin polymerization inhibitor MMAE (HY-15162).

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • Antibody:

    Sigvotatug

  • Linker-Payload:

    VcMMAE

  • Drug-to-Antibody Ratio:

    4

  • Conjugate Type:

    Random Cysteines

  • Purity : 98.42%
  • CAS No.: 2764774-91-4
  • 분자량:150000 (average)
  • 보관:
    Shipping with dry ice

    -80°C, protect from light

  • Biological Activity
  • Chemical Information
  • Protocol
  • 순도&문서
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

견적 받기 해외재고보유

Other size
견적 받기
Please select quantity
Amount: USD 0.00